enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Drugs like Ozempic could protect kidney health in people with ...

   www.aol.com/drugs-ozempic-could-protect-kidney...

   Both obesity and cardiovascular disease can increase a person’s risk of developing kidney disease. A recent study found that semaglutide may help reduce the progression of kidney disease in ...

3. Novo kidney trial finds Ozempic cuts cardiac deaths in diabetics

   www.aol.com/news/novo-kidney-trial-finds-ozempic...

   Novo Nordisk's widely used diabetes drug Ozempic delayed progression of chronic kidney disease in diabetes patients, a large late-stage study found, cutting the risk of death from that and major ...

4. Semaglutide - Wikipedia

   en.wikipedia.org/wiki/Semaglutide

   Semaglutide is an antidiabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight management. [19] [20] [21] It is a peptide similar to the hormone glucagon-like peptide-1 (GLP-1), modified with a side chain. [22] [23] It can be administered by subcutaneous injection or taken orally.

5. What Doctors Want You to Know About Ozempic and Chronic ... - AOL

   www.aol.com/lifestyle/doctors-want-know-ozempic...

   Ozempic may lower the risk of serious complications from chronic kidney disease. Medical providers break down the latest research and potential links. ... 24/7 Help. For premium support please ...

6. SGLT2 inhibitor - Wikipedia

   en.wikipedia.org/wiki/SGLT2_inhibitor

   Sotagliflozin (Inpefa) is a dual SGLT1/SGLT2 inhibitor approved by the FDA in May 2023, to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visit in adults with heart failure or type 2 diabetes, chronic kidney disease, and other cardiovascular risk factors. [37] [38]

7. GLP-1 receptor agonist - Wikipedia

   en.wikipedia.org/wiki/GLP-1_receptor_agonist

   GLP-1 agonists were developed initially for type 2 diabetes. [5] The 2022 American Diabetes Association (ADA) standards of medical care in diabetes include GLP-1 agonist or SGLT2 inhibitor as a first line pharmacological therapy for type 2 diabetes in patients who have or are at high risk for atherosclerotic cardiovascular disease or heart failure.

8. The Surprising Ozempic Side Effects You Need to Know ... - AOL

   www.aol.com/surprising-ozempic-side-effects-know...

   Ozempic side effects include nausea and weight loss. Experts explain the side effects of Ozempic and what to look out for when taking the type 2 diabetes drug.

9. What it's like to take Ozempic and Wegovy, from severe side ...

   www.aol.com/news/ozempic-wegovy-severe-side...

   In clinical trials, 73% of adults taking the highest dose of Wegovy reported gastrointestinal issues. Nausea, diarrhea, vomiting, constipation and stomach pain are most common. Some people have ...